| Primary |
| Hepatitis B |
69.4% |
| Diabetes Mellitus |
6.1% |
| Product Used For Unknown Indication |
4.1% |
| Dyslipidaemia |
3.1% |
| Hepatic Neoplasm Malignant |
3.1% |
| Neoplasm Malignant |
3.1% |
| Hepatic Cirrhosis |
2.0% |
| Lung Infection |
2.0% |
| Pyrexia |
2.0% |
| Antiviral Prophylaxis |
1.0% |
| Arthralgia |
1.0% |
| Diarrhoea |
1.0% |
| Hepatitis |
1.0% |
| Pain |
1.0% |
|
| Thrombocytopenia |
12.8% |
| Osteomalacia |
10.3% |
| Aspartate Aminotransferase Increased |
7.7% |
| Blood Albumin Decreased |
7.7% |
| Renal Injury |
7.7% |
| Alanine Aminotransferase Increased |
5.1% |
| Ascites |
5.1% |
| Hepatic Failure |
5.1% |
| Hypophosphataemia |
5.1% |
| Proteinuria |
5.1% |
| Transaminases Increased |
5.1% |
| Acute Hepatic Failure |
2.6% |
| Blood Bilirubin Increased |
2.6% |
| Blood Creatine Phosphokinase Increased |
2.6% |
| Blood Creatinine Increased |
2.6% |
| Diabetic Nephropathy |
2.6% |
| Drug Ineffective |
2.6% |
| Encephalopathy |
2.6% |
| Genotype Drug Resistance Test Positive |
2.6% |
| Hepatic Function Abnormal |
2.6% |
|
| Secondary |
| Hepatitis B |
28.6% |
| Hiv Infection |
22.4% |
| Antiretroviral Therapy |
18.0% |
| Chronic Hepatitis |
3.7% |
| Thyroid Cancer |
3.3% |
| Diabetes Mellitus |
2.9% |
| Chronic Lymphocytic Leukaemia |
2.4% |
| Drug Use For Unknown Indication |
2.4% |
| Lymphoma |
2.4% |
| Hepatic Cirrhosis |
2.0% |
| Splenic Marginal Zone Lymphoma |
2.0% |
| Diffuse Large B-cell Lymphoma |
1.6% |
| Idiopathic Thrombocytopenic Purpura |
1.6% |
| Acute Myeloid Leukaemia |
1.2% |
| Hepatic Neoplasm Malignant |
1.2% |
| Neoplasm Malignant |
1.2% |
| Hepatitis |
0.8% |
| Hepatitis B Virus |
0.8% |
| Product Used For Unknown Indication |
0.8% |
| Autoimmune Hepatitis |
0.4% |
|
| Renal Injury |
13.4% |
| Viral Infection |
13.4% |
| Hepatitis B |
11.9% |
| No Therapeutic Response |
6.0% |
| Weight Decreased |
6.0% |
| Aspartate Aminotransferase Increased |
4.5% |
| Peripheral Sensory Neuropathy |
4.5% |
| Squamous Cell Carcinoma |
4.5% |
| Acute Hepatic Failure |
3.0% |
| Alanine Aminotransferase Increased |
3.0% |
| Drug Exposure During Pregnancy |
3.0% |
| Hepatic Failure |
3.0% |
| Lactic Acidosis |
3.0% |
| Myalgia |
3.0% |
| Myelitis Transverse |
3.0% |
| Obesity |
3.0% |
| Pancreatitis Acute |
3.0% |
| Renal Failure |
3.0% |
| Trisomy 13 |
3.0% |
| Vomiting |
3.0% |
|
| Concomitant |
| Hepatitis B |
29.0% |
| Hepatic Neoplasm Malignant |
9.0% |
| Hiv Infection |
8.4% |
| Drug Use For Unknown Indication |
7.2% |
| Product Used For Unknown Indication |
6.0% |
| Prophylaxis |
5.4% |
| Nutritional Support |
4.8% |
| B-cell Lymphoma |
4.5% |
| Supplementation Therapy |
3.3% |
| Decreased Appetite |
2.7% |
| Ascites |
2.4% |
| Hepatic Cirrhosis |
2.4% |
| Hypertension |
2.4% |
| Organ Transplant |
2.4% |
| Diarrhoea |
2.1% |
| Anaemia |
1.8% |
| Hepatitis B Virus |
1.8% |
| Liver Disorder |
1.8% |
| Oedema Peripheral |
1.5% |
| Abdominal Pain |
1.2% |
|
| Hbv Dna Increased |
10.1% |
| Vomiting |
10.1% |
| Nausea |
5.8% |
| Oedema Peripheral |
5.8% |
| Pain In Extremity |
5.8% |
| Renal Impairment |
5.8% |
| Tachycardia |
5.8% |
| Therapeutic Response Decreased |
5.8% |
| Viral Mutation Identified |
5.8% |
| White Blood Cell Count Increased |
5.8% |
| Hepatitis B |
4.3% |
| Transaminases Increased |
4.3% |
| Wound |
4.3% |
| Central Nervous System Lymphoma |
2.9% |
| Drug Interaction |
2.9% |
| Gastroenteritis Radiation |
2.9% |
| Hemianopia |
2.9% |
| Hepatic Encephalopathy |
2.9% |
| Hepatic Neoplasm Malignant |
2.9% |
| Hepatitis B Dna Increased |
2.9% |
|
| Interacting |
|
|
